Stockscreener 앱 받기
3.24
27.12%
0.88
시간 외 거래:
3.24
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
Co-Diagnostics Regains Nasdaq Compliance and Listing Status - TipRanks
Co-Diagnostics regains Nasdaq listing compliance - Investing.com
Co-Diagnostics regains Nasdaq listing compliance By Investing.com - Investing.com UK
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements - PR Newswire
Fundamentals Check: Will Co Diagnostics Inc benefit from rising consumer demandJuly 2025 Gainers & Daily Momentum Trading Reports - baoquankhu1.vn
CODX Stock Jumped A Whopping 148% Today: What’s Driving The Super Rally? - Stocktwits
Establishment Labs and Co-Diagnostics: A Comparison of Medical Companies - National Today
Inside Dubai's World Health Expo, Co-Diagnostics meets MENA lab leaders - Stock Titan
India grants license for CoSara PCR device; TB, HPV tests pending - Stock Titan
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform - Morningstar
Co-Diagnostics (CODX) Downgraded to Hold by Maxim Group Today | - GuruFocus
Co-Diagnostics Shares Transition to Over-the-Counter Trading - AD HOC NEWS
Co-Diagnostics Faces Nasdaq Delisting After Bid Price Noncompliance - The Globe and Mail
CODX Stock Price, Forecast & Analysis | CO-DIAGNOSTICS INC (NASDAQ:CODX) - Chartmill
Co-Diagnostics (CODX) Price Target Increased by 2,900.00% to 38.25 - Nasdaq
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market By Investing.com - Investing.com India
Co-Diagnostics to be delisted from Nasdaq, trading to move to OTC Market - Investing.com Nigeria
Co-Diagnostics Received Notice of Delisting - TradingView — Track All Markets
Co-Diagnostics, Inc.(OTCPK: CODX) dropped from NASDAQ Composite Index - marketscreener.com
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships - StreetInsider
Why Co Diagnostics Inc. stock could be next big winnerShare Buyback & Stepwise Trade Execution Plans - Улправда
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention and Expo on Oct 2-3 - marketscreener.com
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Finviz
Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - The Globe and Mail
Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance
Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn
Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus
Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - MarketScreener
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com South Africa
Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com Canada
Co-Diagnostics Announces Reverse Stock Split - Financial Times
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - The Malaysian Reserve
Co-Diagnostics Receives Grant of Australian Patent Covering Co-D - GuruFocus
Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus
Co-diagnostics receives Australian patent for PCR testing platform By Investing.com - Investing.com India
Co-diagnostics receives Australian patent for PCR testing platform - Investing.com
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Can Co-Diagnostics Stock Recover If Markets Fall? - Trefis
Aug Breakouts: How resilient is Co Diagnostics Inc. stock in market downturns - Улправда
2.21%
0.07%
자본화:
|
볼륨(24시간):